Previous research demonstrated that when exposed to sorafenib, HCC cells with decreased RB protein expression level had a death rate 2–3 times higher than that of cells with a normal RB protein expression level, indicating that HCC cells with a low RB protein level were more susceptible to ferroptosis 7. This evidence concerns the gene RB1 and hepatocellular carcinoma.